in this issue
People & Business :: Companies
AMRI to Get BMS Milestone Payment
1:44 PM MDT | July 30, 2007 | Chemical Week Editorial Staff
Albany Molecular Research Inc. (AMRI; Albany, NY) says it will receive a payment of $1.5 million from Bristol-Myers Squibb (BMS) for a chemical compound it developed under license agreement with the pharma company. This is the first milestone in the ongoing research collaboration between the two companies to develop treatments for depression and diseases of the central nervous...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee